Search NASA⌕ Search

SEARCH · Search NASA

Results for “microbiome stability”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

Adding Fresh Produce to the Space Diet

NASA’s Human Research Program has identified a Risk of inadequate nutrition and food stability as a risk of high concern for future long duration exploration missions such as a mission to Mars. One possible solution to help reduce this risk is the addition of in situ produced supplemental fresh produce to supplement and enhance the astronaut diet. A number of ground and ISS-based studies are being conducted which are helping to reduce this risk by filling the gaps in knowledge and technology associated with space crop production. These include studies with the Veggie vegetable production system on the International Space Station. Key focus areas include water and nutrient delivery, food safety and the crop microbiome, crop selection and testing, automation and robotics, radiation impacts, seed storage and handling, and scalability for different concepts and architectures. All of these areas have significant challenges that need to be addressed prior to successful integration of crop production into the crew diet. Data from these studies is feeding the development of new technologies and systems for space crop production. This research was funded by NASA Space Biology and NASA’s Human Research Program.

Gioia Massa↗

Adding Fresh Produce to the Space Diet

NASA’s Human Research Program has identified a Risk of inadequate nutrition and food stability as a risk of high concern for future long duration exploration missions such as a mission to Mars. One possible solution to help reduce this risk is the addition of in situ produced supplemental fresh produce to supplement and enhance the astronaut diet. A number of ground and ISS-based studies are being conducted which are helping to reduce this risk by filling the gaps in knowledge and technology associated with space crop production. These include studies with the Veggie vegetable production system on the International Space Station. Key focus areas include water and nutrient delivery, food safety and the crop microbiome, crop selection and testing, automation and robotics, radiation impacts, seed storage and handling, and scalability for different concepts and architectures. All of these areas have significant challenges that need to be addressed prior to successful integration of crop production into the crew diet. Data from these studies is feeding the development of new technologies and systems for space crop production. This research was funded by NASA Space Biology and NASA’s Human Research Program.

Space Crop Production↗

Circulating miRNA Signature Predicts Health Risks Associated with Radiation and Microgravity

The many known health risks currently associated with space travel include increased risk of cardiovascular disease, cancer, central nervous system related diseases, muscle degeneration, and changes with host-gut microbiome interactions that can have profound impact with these and other health risks. The majority of the risk from space travel stem of the two components of the space environment which are microgravity and radiation. From our earlier work (Beheshti et al, PLOS One, 2018), we predicted that there is a systemic component of the host that causes general increased health risks due to spaceflight driven by a circulating microRNA (miRNA) signature consisting of 13 miRNAs that directly regulates both p53 and TGF1. MiRNAs are small non-coding RNA molecules with a negative and post-transcriptional regulation on gene expression) are increasingly recognized as major systemic regulators of responses to stressors, including microgravity, oxidative stress, and DNA damage. In addition, due to the size and stability of miRNAs, it is known that miRNAs can circulate throughout the body and have been found in the majority of the bodily fluids including blood, urine, saliva, and tears. Here, we start to dissect the actual impact of this miRNA signature on both the radiation and microgravity components and prove that this miRNA signature actually exists in the circulation of a host. To achieve this, we obtained multiple tissues including, serum, liver, and spleen and utilizing droplet digital PCR (ddPCR), we start to show how this circulating miRNA signature impacts which component of the spaceflight. The tissue was obtained from experiments performed on C57BL/6 male mice (N=10 for each condition) that were hindlimb unloaded (HU) to simulated microgravity, irradiated with 2Gy gamma (IR), HU plus IR, and control mice under normal conditions. It was shown that these miRNAs were present in the serum as predicted by the in silico prediction from our earlier predictions. The HU vs Controls show significant increases of the predicted miRNAs in the serum for more than half of the miRNA signature, with remaining miRNAs increasing comparing to the controls close to statistical significance. IR vs control mice showed increases for the miRNAs, but not has pronounced as the HU conditions. Finally, the combination of the HU+IR vs controls showed increases for the majority of the miRNA signature. The data indicates that the miRNA signature originally predicted through in silico methods is mainly associated with the microgravity component and is circulating throughout the host resulting in a systemic impact of the miRNAs on the host. These miRNAs are shown in the literature to potentially increase health risks associated with several diseases. In addition, we have begun testing the potential of utilizing antagonists to this miRNA signature to act as a potential countermeasure to mitigate radiation impact on the organism. This work demonstrates for the first time the potential of a minimally invasive novel biomarker and countermeasure that can be used to mitigate both radiation and microgravity effects.

Beheshti, Afshin↗

Systemic Alterations with Spaceflight Associated Health Risks Originating from Both Circulating miRNAs and Mitochondrial Biology

The many known health risks currently associated with space travel include increased risk of cardiovascular disease, cancer, central nervous system related diseases, muscle degeneration, and changes with host-gut microbiome interactions that can have profound impact with these and other health risks. The majority of the risk from space travel stem of the two components of the space environment which are microgravity and radiation. Two specific systemic effects have been uncovered by us to impact the body as a whole due to the space environment. One factor is related from our earlier work (Beheshti et al, PLOS One, 2018), we predicted that there is a systemic component of the host that causes general increased health risks due to spaceflight driven by a circulating microRNA (miRNA) signature consisting of 13 miRNAs that directly regulates both p53 and TGF1. MiRNAs are small non-coding RNA molecules with a negative and post-transcriptional regulation on gene expression) are increasingly recognized as major systemic regulators of responses to stressors, including microgravity, oxidative stress, and DNA damage. In addition, due to the size and stability of miRNAs, it is known that miRNAs can circulate throughout the body and have been found in the majority of the bodily fluids including blood, urine, saliva, and tears. Here, we start to dissect the actual impact of this miRNA signature on both the radiation and microgravity components and prove that this miRNA signature actually exists in the circulation of a host. The other systemic factor we uncovered was the impact the mitochondria on the whole body due to spaceflight. We hypothesize that spaceflight may promote a physiologic response driven by systemic mitochondria pathways leading to metabolic disorder stemming from the liver and directly impacting other organs and tissues. A systems biology method was implemented utilizing GeneLab datasets that involved in vitro experiments performed at the low Earth orbit, in vivo experiments involving mice flown to space, and finally human physiological data from astronauts. A comprehensive multi-omics approach was implemented which involved correlating transcriptomic analysis with proteomics, metabolomics, and methylation analysis. This approach led us to confirm our hypothesis that a systemic mitochondrial driven response is responsible for increasing potential health risk and is conserved from the in vitro studies, to the in vivo studies, and finally confirmed in astronauts.

Radiation↗